R J Jacobs

Summary

Affiliation: Capitol Outcomes Research
Country: USA

Publications

  1. ncbi The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A
    R Jake Jacobs
    Capitol Outcomes Research, Alexandria, Virginia 22310, USA
    Am J Gastroenterol 97:427-34. 2002
  2. ncbi Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates
    R Jake Jacobs
    Capitol Outcomes Research Inc, 6188 Old Franconia Road, Alexandria, VA 22310, USA University of California at San Francisco, San Francisco, CA, USA
    Vaccine 22:1241-8. 2004
  3. ncbi The cost effectiveness of hepatitis immunization for US college students
    R Jake Jacobs
    Capitol Outcomes Research, Alexandria, Virginia 22310, USA
    J Am Coll Health 51:227-36. 2003
  4. ncbi An economic assessment of pre-vaccination screening for hepatitis A and B
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, VA 22310, USA
    Public Health Rep 118:550-8. 2003
  5. ncbi Valuation of symptomatic hepatitis a in adults: estimates based on time trade-off and willingness-to-pay measurement
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, Virginia 22310, USA
    Pharmacoeconomics 20:739-47. 2002
  6. ncbi Regional variation in the cost effectiveness of childhood hepatitis A immunization
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, VA 22310, USA
    Pediatr Infect Dis J 22:904-14. 2003
  7. ncbi Effect of middle school entry requirements on hepatitis B vaccination coverage
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, Virginia 22310, USA
    J Adolesc Health 34:420-3. 2004
  8. ncbi Immunization needs of chronic liver disease patients seen in primary care versus specialist settings
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, Virginia 22310, USA
    Dig Dis Sci 50:1525-31. 2005
  9. ncbi The cost-effectiveness of adolescent hepatitis A vaccination in states with the highest disease rates
    R J Jacobs
    Capitol Outcomes Research Inc, 6188 Old Franconia Rd, Alexandria, VA 22310, USA
    Arch Pediatr Adolesc Med 154:763-70. 2000
  10. ncbi Economic value to parents of reducing the pain and emotional distress of childhood vaccine injections
    A S Meyerhoff
    Capitol Outcomes Research, Inc, Alexandria, VA 22310, USA
    Pediatr Infect Dis J 20:S57-62. 2001

Collaborators

Detail Information

Publications26

  1. ncbi The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A
    R Jake Jacobs
    Capitol Outcomes Research, Alexandria, Virginia 22310, USA
    Am J Gastroenterol 97:427-34. 2002
    ..Consistent with other medical interventions for chronic hepatitis C patients, cost-effectiveness is most favorable for younger patients...
  2. ncbi Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates
    R Jake Jacobs
    Capitol Outcomes Research Inc, 6188 Old Franconia Road, Alexandria, VA 22310, USA University of California at San Francisco, San Francisco, CA, USA
    Vaccine 22:1241-8. 2004
    ..In the three regions considered, cost effectiveness would be US$ <0, 2131, and 22,819 per life-year saved, respectively. Prison-based hepatitis A/B immunization would meet accepted standards of cost effectiveness throughout the US...
  3. ncbi The cost effectiveness of hepatitis immunization for US college students
    R Jake Jacobs
    Capitol Outcomes Research, Alexandria, Virginia 22310, USA
    J Am Coll Health 51:227-36. 2003
    ..Until childhood and adolescent vaccination can produce immune cohorts of young adults, college-based hepatitis immunization can reduce disease transmission in a cost-effective manner...
  4. ncbi An economic assessment of pre-vaccination screening for hepatitis A and B
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, VA 22310, USA
    Public Health Rep 118:550-8. 2003
    ....
  5. ncbi Valuation of symptomatic hepatitis a in adults: estimates based on time trade-off and willingness-to-pay measurement
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, Virginia 22310, USA
    Pharmacoeconomics 20:739-47. 2002
    ..This endpoint does not consider the benefits of preventing nonfatal yet symptomatic infections. Nearly as many days of healthy life are lost to hepatitis A morbidity as mortality...
  6. ncbi Regional variation in the cost effectiveness of childhood hepatitis A immunization
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, VA 22310, USA
    Pediatr Infect Dis J 22:904-14. 2003
    ..Routine childhood hepatitis A immunization is recommended in regions with incidence rates twice the national average, but it may be cost-effective in a wider geographic area...
  7. ncbi Effect of middle school entry requirements on hepatitis B vaccination coverage
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, Virginia 22310, USA
    J Adolesc Health 34:420-3. 2004
    ..Nonetheless, establishment of mandates in states without them could significantly reduce hepatitis B transmission...
  8. ncbi Immunization needs of chronic liver disease patients seen in primary care versus specialist settings
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, Virginia 22310, USA
    Dig Dis Sci 50:1525-31. 2005
    ..The higher coverage rates evident in centers vaccinating on-site suggests a breakdown may occur when patients are referred to alternative vaccination venues...
  9. ncbi The cost-effectiveness of adolescent hepatitis A vaccination in states with the highest disease rates
    R J Jacobs
    Capitol Outcomes Research Inc, 6188 Old Franconia Rd, Alexandria, VA 22310, USA
    Arch Pediatr Adolesc Med 154:763-70. 2000
    ....
  10. ncbi Economic value to parents of reducing the pain and emotional distress of childhood vaccine injections
    A S Meyerhoff
    Capitol Outcomes Research, Inc, Alexandria, VA 22310, USA
    Pediatr Infect Dis J 20:S57-62. 2001
    ....
  11. ncbi Cost effectiveness of vaccinating food service workers against hepatitis A infection
    R J Jacobs
    Capitol Outcomes Research, Inc, Alexandria, Virginia 22310, USA
    J Food Prot 63:768-74. 2000
    ..A vaccination policy would reduce societal costs while costing the health system $13,969 per YOLS, a ratio that exceeds generally accepted standards of cost effectiveness...
  12. ncbi Transmission of hepatitis A through household contact
    A S Meyerhoff
    Capitol Outcomes Research Inc, Alexandria, VA 22310, USA
    J Viral Hepat 8:454-8. 2001
    ..Evaluations of hepatitis A prevention should consider the ability of immunization to protect household and other personal contacts...
  13. ncbi Comparative cost effectiveness of varicella, hepatitis A, and pneumococcal conjugate vaccines
    R J Jacobs
    Capitol Outcomes Research, Inc, Alexandria, Virginia 22310, USA
    Prev Med 33:639-45. 2001
    ..Cost-effectiveness assessments should aid the establishment of vaccination priorities, but comparing results of published studies is confounded by their dissimilar methods...
  14. ncbi Do too many shots due lead to missed vaccination opportunities? Does it matter?
    A S Meyerhoff
    Capitol Outcomes Research, Inc, 6188 Old Franconia Road, Alexandria, VA 22310, USA
    Prev Med 41:540-4. 2005
    ..Little is known about the relationship between the number of vaccine doses due and whether all scheduled doses are administered, and the effect of dose deferral on immunization coverage...
  15. ncbi Clinician satisfaction with vaccination visits and the role of multiple injections, results from the COVISE Study (Combination Vaccines Impact on Satisfaction and Epidemiology)
    A Meyerhoff
    Capitol Outcomes Research, Inc, Alexandria, VA 22310, USA
    Clin Pediatr (Phila) 43:87-93. 2004
    ..01). Satisfaction decreased markedly, on each measure, at 4-injection visits, 5-injection visits, or both...
  16. ncbi Hepatitis A immunization strategies: universal versus targeted approaches
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, VA 22310, USA
    Clin Pediatr (Phila) 44:705-9. 2005
    ..Because adult vaccination is more costly per capita, targeted vaccination may provide modest financial savings with none of the benefits associated with reduced child-to-adult transmission...
  17. ncbi Hepatitis B risks and immunization coverage among American travelers
    Bradley A Connor
    Division of Gastroentesiogy and Hepatology, Weill Medical College of Cornell University, New York, NY, USA
    J Travel Med 13:273-80. 2006
    ..A substantial share are candidates for hepatitis B vaccination based on their domestic activities, and/or face hepatitis B risks during travel...
  18. ncbi Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted
    Alejandro Ellis
    Secretariat of Health of the City of Buenos Aires, Buenos Aires, Argentina
    Rev Panam Salud Publica 21:345-56. 2007
    ....
  19. ncbi Prevalence of hepatitis A virus risk factors in a very low endemic country, Switzerland
    Meichun Mohler Kuo
    Division of Epidemiology and Prevention of Non Communicable Diseases, Institute of Social and Preventive Medicine, University of Zurich, Hirschengraben 84, CH 8001 Zurich, Switzerland
    Vaccine 25:8718-25. 2007
    ....
  20. ncbi Projected cost-effectiveness of new vaccines for adolescents in the United States
    Ismael R Ortega-Sanchez
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mail Stop A 47, Atlanta, GA 30333, USA
    Pediatrics 121:S63-78. 2008
    ..However, important considerations that limit the utility of these assessments, such as the diversity of approaches used, are often overlooked and should be better understood...
  21. ncbi Re: Arguedas et al.--Hepatitis A prevention analysis
    R Jake Jacobs
    Am J Gastroenterol 97:2924-5; author reply 2925. 2002
  22. ncbi Cost-effectiveness of hepatitis A/B vaccination in the private sector
    R Jake Jacobs
    Sex Transm Dis 32:465. 2005
  23. ncbi Cost-effectiveness of universal childhood hepatitis A vaccination in Chile
    M Teresa Valenzuela
    School of Public Health, Faculty of Medicine, University of Chile, Santiago, Chile
    Vaccine 23:4110-9. 2005
    ..Further, approximately 70 fatal infections would be averted and >4600 quality-adjusted life years would be saved. This analysis supports the cost-effectiveness of universal childhood hepatitis A vaccination in Chile...
  24. ncbi Cost-effectiveness of hepatitis A-B vaccine versus hepatitis B vaccine for healthcare and public safety workers in the western United States
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, Virginia 22310, USA
    Infect Control Hosp Epidemiol 25:563-9. 2004
    ..CONCLUSION: For healthcare and public safety workers in western states, substituting hepatitis A-B vaccine for hepatitis B vaccine would reduce morbidity, mortality, and costs...
  25. ncbi Cost-effectiveness of hepatitis A/B vaccine versus hepatitis B vaccine in public sexually transmitted disease clinics
    R Jake Jacobs
    Capitol Outcomes Research, Inc, Alexandria, VA 22310, USA
    Sex Transm Dis 30:859-65. 2003
    ..Many patients seen at U.S. sexually transmitted disease (STD) clinics are offered hepatitis B vaccination. Substituting hepatitis A/B vaccine would provide additional protection but increase costs...
  26. ncbi Universal hepatitis A vaccination in the United States: a call for action
    Jay M Lieberman
    University of California, Irvine School of Medicine, Irvine, CA, USA
    Pediatr Infect Dis J 27:287-91. 2008
    ....